Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cystic fibrosis modifier genes.

Jane Davies1, Eric Alton, Uta Griesenbach

  • 1Department of Gene Therapy, Faculty of Medicine, Imperial College, Emmanuel Kaye Building, Manresa Road, London, UK. j.c.davies@imperial.ac.uk

Journal of the Royal Society of Medicine
|July 20, 2005
PubMed
Summary

Identifying modifier genes for cystic fibrosis (CF) lung disease is complex. Research suggests multiple gene combinations, not single genes, influence CFTR-related disease severity, posing research challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

F/HN-pseudotyped lentiviral vector efficiently transduces non-human primate airways with no evidence of relevant toxicity.

Molecular therapy. Advances·2026
Same author

Assessment of F/HN-pseudotyped lentiviral vector following intravenous delivery to mice.

Gene therapy·2026
Same author

Cefazolin for Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia.

The New England journal of medicine·2026
Same author

Diphtheria outbreak, Northern Territory of Australia, 2025 to 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity.

Nature communications·2026
Same author

Diagnostic models for male lower urinary tract symptom management in primary care.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026

Area of Science:

  • Genetics
  • Pulmonology
  • Medical Research

Background:

  • Cystic Fibrosis (CF) lung disease severity is not reliably predicted by CFTR genotype alone.
  • Several candidate genes have been investigated as modifiers of CFTR function and disease progression.
  • Understanding genetic modifiers is crucial for improving CF prognosis and treatment.

Purpose of the Study:

  • To explore the role of genetic modifiers in cystic fibrosis pulmonary disease.
  • To investigate the complex interplay of multiple genes in CF pathogenesis.
  • To identify potential targets for novel therapeutic strategies in CF.

Main Methods:

  • Candidate gene association studies.
  • Haplotype analysis to assess combined genetic effects.

Related Experiment Videos

  • Statistical modeling to evaluate gene-gene interactions.

    • Main Results:

    • CFTR genotype alone is insufficient for predicting CF lung disease severity.
    • Multiple genetic factors likely contribute to disease variability.
    • Identifying specific gene combinations presents significant methodological challenges.

    Conclusions:

    • The genetic basis of CF lung disease severity is polygenic.
    • Future research should focus on combinatorial genetic approaches.
    • Advancing the understanding of CF pathogenesis may lead to personalized treatment strategies.